CSS-SR Validation Study
Validation of the CRPS Severity Score-Self Report
1 other identifier
observational
100
1 country
1
Brief Summary
Complex Regional Pain Syndrome (CRPS) is an orphan condition with no interventions proven effective in large-scale clinical trials. In-person clinical evaluations are required to make a CRPS diagnosis and determine study eligibility, making recruitment for CRPS trials challenging. To address this barrier, we will validate a self-report measure of CRPS symptom severity suitable for remote administration that was created by colleagues at Vanderbilt University. The aim of this study is to evaluate the correspondence at the item and total score level between the proposed self-report measure (CRPS Severity Score-Self Report; CSS-SR) and an existing validated measure of CRPS signs and symptoms derived from clinical history and physical examination data (CSS-Clinician version) and evaluate its diagnostic accuracy relative to clinically determined, criterion-based CRPS diagnosis using the Budapest criteria.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2025
CompletedStudy Start
First participant enrolled
January 27, 2025
CompletedFirst Posted
Study publicly available on registry
January 29, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 29, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 29, 2026
February 13, 2026
January 1, 2026
1.9 years
January 22, 2025
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concordance between CSS-Clinician and CSS-SR total scores
Concordance between CSS-Clinician total scores, which will be on a numerical scale potentially ranging from 0-16, and CSS-SR total scores, which will be on a numerical scale potentially ranging from 0-13. Higher scores indicate greater CRPS symptom severity while lower scores indicate a lesser degree of symptom severity. Concordance (corrected for chance agreement) between CSS-Clinician and CSS-SR items and total scores will be assessed using intraclass correlations (ICCs; two-way random effects model; potential range = -1.00 to 1.00). Strength of agreement will be evaluated for descriptive purposes based on published recommendations: \< 0.50 = poor agreement, 0.50 - 0.75 = moderate agreement, 0.76 - 0.90 = good agreement, and \>0.90 = excellent agreement. All analyses will use the maximum number of cases available with a two-sided p\<0.05 criterion for statistical significance.
Date of enrollment
Secondary Outcomes (1)
Diagnostic accuracy relative to clinically-determined, criterion-based CRPS diagnosis using the Budapest criteria
Date of enrollment
Study Arms (2)
CRPS group
Patients suspected or diagnosed with unilateral CRPS type I or II of the upper or lower extremity
Non-CRPS group
Patients suspected or diagnosed with non-CRPS-related pain of the upper or lower extremities
Interventions
Self-report tool in a questionnaire format to capture CPRS Severity Score.
Eligibility Criteria
Hospital for Special Surgery Outpatient Pain Management Patients
You may qualify if:
- years of age or older
- Suspected or diagnosed with unilateral CRPS type I or II of the upper or lower extremity
- Suspected or diagnosed with non-CRPS-related pain of the upper or lower extremities
You may not qualify if:
- Bilateral CRPS
- Total knee arthroplasty as the inciting event of CRPS
- Less than 18 years of age
- Non-English speaking
- Inability to comprehend study protocol and questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital for Special Surgery, New Yorklead
- Vanderbilt Universitycollaborator
Study Sites (1)
Hospital for Special Surgery
New York, New York, 10021, United States
Related Publications (3)
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Hauser W, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011 Jun;38(6):1113-22. doi: 10.3899/jrheum.100594. Epub 2011 Feb 1.
PMID: 21285161BACKGROUNDDeyo RA, Dworkin SF, Amtmann D, Andersson G, Borenstein D, Carragee E, Carrino J, Chou R, Cook K, DeLitto A, Goertz C, Khalsa P, Loeser J, Mackey S, Panagis J, Rainville J, Tosteson T, Turk D, Von Korff M, Weiner DK. Report of the NIH Task Force on research standards for chronic low back pain. J Pain. 2014 Jun;15(6):569-85. doi: 10.1016/j.jpain.2014.03.005. Epub 2014 Apr 29.
PMID: 24787228BACKGROUNDBruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology. 2010 Sep;113(3):713-25. doi: 10.1097/ALN.0b013e3181e3db38.
PMID: 20693883BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandra Sideris, PhD
Hospital for Special Surgery, New York
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2025
First Posted
January 29, 2025
Study Start
January 27, 2025
Primary Completion (Estimated)
December 29, 2026
Study Completion (Estimated)
December 29, 2026
Last Updated
February 13, 2026
Record last verified: 2026-01